Ruxolitinib is a selective Janus kinase (JAK) inhibitor commonly used under the brand name Jakafi for the treatment of myelofibrosis and polycythemia vera. By targeting JAK1 and JAK2 enzymes, it helps regulate the overactive signaling pathways involved in these hematologic disorders. Maintaining the pharmaceutical purity of Ruxolitinib is essential to ensure its therapeutic efficacy, patient safety, and adherence to regulatory standards. Impurity profiling is crucial for detecting and controlling unwanted by-products that may arise during manufacturing, storage, or degradation. Here are some of its known impurities listed below.
Showing 1 - 5 of 5 products
Catalogue No : RUXO-OCL-005
CAS No : 1911644-32-0
In Stock
Synonyms
3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanamide
3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanamide
Catalogue No : RUXO-OCL-001
CAS No : 941688-05-7
In Stock
Synonyms
β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile
β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile
Catalogue No : RUXO-OCL-002
CAS No : 941685-26-3
In Stock
Synonyms
4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine
4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine
Catalogue No : RUXO-OCL-003
CAS No : 941685-27-4
In Stock
Synonyms
4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine
4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine
Catalogue No : RUXO-OCL-004
CAS No : 952518-97-7
In Stock
Synonyms
4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine
4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine